179 related articles for article (PubMed ID: 14167340)
1. THERAPY OF CYCLIC DYSFUNCTION.
LAPOINTE R
Appl Ther; 1964 Jun; 6():518-9. PubMed ID: 14167340
[No Abstract] [Full Text] [Related]
2. MENOMETRORRHAGIA: A NEW APPROACH TO THERAPY.
CROCKER KM
Appl Ther; 1964 Jun; 6():520-1. PubMed ID: 14167341
[No Abstract] [Full Text] [Related]
3. THE THERAPEUTIC POTENTIAL OF NORETHINDRONE WITH MESTRANOL IN FUNCTIONAL BLEEDING.
SMITH GG; DICKINSON JH
Appl Ther; 1964 Jun; 6():525-7. PubMed ID: 14167344
[No Abstract] [Full Text] [Related]
4. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
5. [PRACTICAL EXPERIENCES WITH OVULATION INHIBITORS].
HAUSER GA
Bibl Gynaecol; 1965; 32():123-34. PubMed ID: 14238623
[No Abstract] [Full Text] [Related]
6. [PRACTICAL EXPERIENCES WITH OVULATION INHIBITORS].
GERBER E
Bibl Gynaecol; 1965; 32():135-40. PubMed ID: 14238624
[No Abstract] [Full Text] [Related]
7. NORETHINDRONE MESTRANOL AS A THERAPEUTIC AGENT.
CAMERON WJ; WARREN JC
Appl Ther; 1964 Jun; 6():511-8. PubMed ID: 14167339
[No Abstract] [Full Text] [Related]
8. 2 MG. NORETHINDRONE-MESTRANOL IN CONTRACEPTION AND THERAPY.
FRANCIS WG
Appl Ther; 1964 May; 6():419-23. PubMed ID: 14144492
[No Abstract] [Full Text] [Related]
9. [ON METHODOLOGY AND HORMONAL EXCRETION IN DRUG-INDUCED OVULATION INHIBITION].
KAISER R; DAUME E
Bibl Gynaecol; 1965; 32():215-20. PubMed ID: 14238634
[No Abstract] [Full Text] [Related]
10. NORETHINDRONE-MESTRANOL AS A THERAPEUTIC AGENT.
CAMERON WJ; WARREN JC
Fertil Steril; 1965; 16():85-96. PubMed ID: 14256104
[No Abstract] [Full Text] [Related]
11. GENERAL SUMMARY: TREATMENT OF EXCESSIVE BLEEDING AND AMENORRHEA.
BEHRMAN SJ
Mod Treat; 1965 Jan; 2():199-212. PubMed ID: 14257804
[No Abstract] [Full Text] [Related]
12. [STUDIES ON THE ACTION AND SIDE EFFECTS OF NORETHYNODREL AND ETHYNODIOL DIACETATE].
SOOST HJ; MEHRING W
Bibl Gynaecol; 1965; 32():183-7. PubMed ID: 14238631
[No Abstract] [Full Text] [Related]
13. MENSTRUATION AND THE ADOLESCENT.
STURGIS SH
Med Clin North Am; 1965 Mar; 49():405-20. PubMed ID: 14281462
[No Abstract] [Full Text] [Related]
14. CLINICAL EVALUATION OF THE ORAL CONTRACEPTIVE USE OF NORETHINDRONE 5 MG. PLUS MESTRANOL 0.075 MG.
BOARD JA
Can Med Assoc J; 1965 Apr; 92(15):814-7. PubMed ID: 14272499
[TBL] [Abstract][Full Text] [Related]
15. [CLINICAL USE OF A NEW ORAL PROGESTOGEN: CHLORMADINONE].
DELCORRAL F; ARTUZ A; SALCEDO CA; ERAZO JV; ANGEL G
Rev Colomb Obstet Ginecol; 1963; 14():605-23. PubMed ID: 14117499
[No Abstract] [Full Text] [Related]
16. OVULATION INHIBITORS.
CROCKER KM; STITT WD
Can Med Assoc J; 1964 Mar; 90(12):713-6. PubMed ID: 14130491
[TBL] [Abstract][Full Text] [Related]
17. [PRACTICAL EXPERIENCES WITH OVULATION INHIBITION].
KAISER R
Bibl Gynaecol; 1965; 32():107-11. PubMed ID: 14238619
[No Abstract] [Full Text] [Related]
18. [SYNTHETIC PROGESTATIONA. SUBSTANCES IN GYNECOLOGY. CURRENT INDICATIONS FOR NORETHYNODREL].
VILLEDIEU P
Rev Prat; 1964 Jan; 14():77-88. PubMed ID: 14109292
[No Abstract] [Full Text] [Related]
19. [CLINICAL AND BIOCHEMICAL OBSERVATIONS ON A COMBINATION OF ETHINYL ESTRENOL AND MESTRANOL (LYNDIOL)].
ARNOLD M; RICHTER RH
Bibl Gynaecol; 1965; 32():159-64. PubMed ID: 14238628
[No Abstract] [Full Text] [Related]
20. THE BIOLOGICAL EFFECTS OF 2 MG. NORETHINDRONE WITH MESTRANOL.
MERRITT RI
Appl Ther; 1964 May; 6():427-9. PubMed ID: 14144494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
